Neal Gilmer is maintaining his “Buy” rating and C$21.00 target price, citing strong margins, robust cash flow and continued ...

Knight Therapeutics is continuing to build momentum, according to Stifel Nicolaus Canada analyst Justin Keywood.

5N Plus’s quarterly revenue rose 36.7% year over year to $88.9-million, beating both Ventum’s $70.6-million and the Street’s ...

Haywood Capital Markets analyst Neal Gilmer says Verano Holdings ( Verano Holdings Stock Quote, Chart, News, Analysts, ...

Roth Capital Partners has raised its price target on Groupon ( Groupon Inc Stock Quote, Chart, News, Analysts, Financials ...

ATB Capital Markets analyst Martin Toner has to maintained his “Outperform” rating and $210.00 price target on KXS.

ATB Capital Markets is sticking with its bullish view on Bitfarms, maintaining an Outperform rating and a $3.75 price target ...

In a May 5 investor note, Leede Financial analyst Douglas Loe reiterated his Speculative Buy rating and $3.00 target for ...

Spectral is a clinical-stage medical device company focused on developing therapies for critical care, particularly septic ...

Ballard Power’s disappointing Q1 2025 results prompted Roth Capital Partners analyst Craig Irwin to reaffirm his $1.25 price ...

In his May 7 corporate update, Leung remained bullish on Well Health’s positioning as a consolidator in Canada’s healthcare ...

In his May 6 corporate update, Goff said Propel’s revenue, EPS growth and ROE stand out among its fintech peers.